Industry:Biotech & Pharma
Ambit Biosciences Corp
Ambit Biosciences Corp (AMBI:US)
was acquired by 4568:JP
Ambit Biosciences Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule and orally administered enzyme inhibitors for the treatment of acute myeloid leukemia and inflammatory diseases. Ambit Biosciences operates in the United States.